559 related articles for article (PubMed ID: 15488025)
1. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
[TBL] [Abstract][Full Text] [Related]
2. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
3. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
4. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
5. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
6. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
Lomoio S; Scherini E; Necchi D
Brain Res; 2009 Nov; 1297():198-206. PubMed ID: 19703431
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
8. Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.
Ferrer I
Neurotox Res; 2004; 6(6):469-75. PubMed ID: 15658002
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
10. Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits.
Pugliese M; Mascort J; Mahy N; Ferrer I
Acta Neuropathol; 2006 Aug; 112(2):175-83. PubMed ID: 16775693
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
[TBL] [Abstract][Full Text] [Related]
12. Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick's disease.
Puig B; Vinals F; Ferrer I
Acta Neuropathol; 2004 Mar; 107(3):185-9. PubMed ID: 14689204
[TBL] [Abstract][Full Text] [Related]
13. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
[TBL] [Abstract][Full Text] [Related]
14. Stress-induced activation of c-Jun N-terminal kinase in sensory ganglion neurons: accumulation in nuclear domains enriched in splicing factors and distribution in perichromatin fibrils.
Pena E; Berciano MT; Fernandez R; Crespo P; Lafarga M
Exp Cell Res; 2000 Apr; 256(1):179-91. PubMed ID: 10739665
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
16. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
[TBL] [Abstract][Full Text] [Related]
17. Abnormal processing of tau in the brain of aged TgCRND8 mice.
Bellucci A; Rosi MC; Grossi C; Fiorentini A; Luccarini I; Casamenti F
Neurobiol Dis; 2007 Sep; 27(3):328-38. PubMed ID: 17656099
[TBL] [Abstract][Full Text] [Related]
18. Expression of transcription factors c-Fos, c-Jun, CREB-1 and ATF-2, and caspase-3 in relation with abnormal tau deposits in Pick's disease.
Nieto-Bodelón M; Santpere G; Torrejón-Escribano B; Puig B; Ferrer I
Acta Neuropathol; 2006 Apr; 111(4):341-50. PubMed ID: 16496165
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
20. Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.
Middlemas A; Delcroix JD; Sayers NM; Tomlinson DR; Fernyhough P
Brain; 2003 Jul; 126(Pt 7):1671-82. PubMed ID: 12805110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
